Andy AI

Andy AI fills a narrow but painful gap: home health documentation for Medicare/PDGM. Most scribing tools ignore OASIS complexity, but Andy leans into it. The dual AI-human review for coding and scoring adds a layer of trust that pure AI tools lack. Where it shines: high-volume agencies with complex patients. The built-in QA cross-checks hospital records and flags inconsistencies before submission. That alone can save hours of manual review. The wound documentation and medication list generation are also well-executed. Where it falls short: it's useless outside home health. No acute care, no outpatient clinics. The reliance on human reviewers also means turnaround isn't instant — good for accuracy, less good for same-day completion. Pricing is opaque (contact sales), which is a red flag for small agencies on tight budgets. Compared to tools like Augmedix or Suki (general medical scribing), Andy wins on OASIS/PDGM specificity but loses on breadth. If you're a hospital system, look elsewhere. If you run a home health agency, it's probably the best fit. In practice, adoption is easy — two taps to start a visit — and clinicians report loving the simplicity. The quoted $200/30-day revenue lift is anecdotal but plausible given PDGM optimization. We'd recommend a trial for any agency with >50 patients/month.